Sigilon: Sigilon Therapeutics : Acquisition/Asset Disposal - Form 8-K
(marketscreener.com) 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 ...https://www.marketscreener.com/quote/stock/SIGILON-THERAPEUTICS-INC-116081124/news/Sigilon-Therapeutics-Acquisition-Asset-Disposal-Form-8-K-44595620/?utm_medium=RSS&utm_content=20230811
Read full article »
Sigilon is a Massachusetts-based biopharmaceutical company that researches and develops cell therapies for the treatment of chronic diseases.
Read more